Literature DB >> 16399488

Insulin resistance/compensatory hyperinsulinemia predict carotid intimal medial thickness in patients with essential hypertension.

Ivana Zavaroni1, Diego Ardigò, Alessandra Zuccarelli, Edoarda Pacetti, Pier M Piatti, Lucilla Monti, Silvia Valtueña, Paola Massironi, Pier C Rossi, Gerald M Reaven.   

Abstract

BACKGROUND AND AIM: Approximately 50% of subjects with essential hypertension (EH) are insulin resistant, and this defect in insulin action could contribute to increased cardiovascular disease (CVD) risk in these patients. To test this hypothesis, we attempted to see if there was a link between insulin resistance (IR) and carotid intimal medial thickness (IMT), an early index of CVD, in patients with essential hypertension. METHODS AND
RESULTS: Ultrasound quantification of carotid IMT was performed in 79 hypertensive patients, and 63 patients (31 m and 32 f), defined as being free of plaque (IMT < 1.3 mm), were further subdivided into normal (<1.0 mm) and thickened (1-1.3 mm) IMT groups. Subjects in the thickened IMT group were older and had significantly (p < 0.05) higher plasma concentrations of fasting insulin, nitric oxide (NO(x)) and intercellular adhesion molecule 1 (ICAM-1). However, the two groups were not significantly different in terms of blood pressure, overall or regional obesity, fasting lipid levels, uric acid, concentrations of other cellular adhesion molecules or levels of C-reactive protein. There were significant (p < 0.05) correlations in the whole population between IMT and age, fasting insulin and NO(x), and multiple regression analysis identified fasting insulin as an independent predictor of IMT.
CONCLUSIONS: The presence of increased IMT is significantly related to several metabolic and endothelial abnormalities associated with IR/hyperinsulinemia, and fasting insulin independently predicts the thickness of the intima-media layer. These results support the view that CVD risk is greatest in those patients with essential hypertension who are also IR/hyperinsulinemic.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16399488     DOI: 10.1016/j.numecd.2004.11.003

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  8 in total

1.  The association of midlife cardiorespiratory fitness with later life carotid atherosclerosis: Cooper Center Longitudinal Study.

Authors:  Joowon Lee; Baojiang Chen; Harold W Kohl; Carolyn E Barlow; Chong do Lee; Nina B Radford; Laura F DeFina; Kelley Pettee Gabriel
Journal:  Atherosclerosis       Date:  2019-01-24       Impact factor: 5.162

Review 2.  Genetics Insights in the Relationship Between Type 2 Diabetes and Coronary Heart Disease.

Authors:  Mark O Goodarzi; Jerome I Rotter
Journal:  Circ Res       Date:  2020-05-21       Impact factor: 17.367

3.  Chronic insulin treatment amplifies PDGF-induced motility in differentiated aortic smooth muscle cells by suppressing the expression and function of PTP1B.

Authors:  Daming Zhuang; Qinghua Pu; Bogdan Ceacareanu; Yingzi Chang; Madhulika Dixit; Aviv Hassid
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-02       Impact factor: 4.733

4.  Noninvasive assessment of subclinical atherosclerosis in normotensive gravidae with gestational diabetes.

Authors:  A E Atay; H Simsek; B Demir; M N Sakar; M Kaya; S Pasa; S Demir; D Sit
Journal:  Herz       Date:  2013-07-18       Impact factor: 1.443

5.  Retinal vessel abnormalities are associated with elevated fasting insulin levels and cerebral atrophy in nondiabetic individuals.

Authors:  Aziz Tirsi; Hannah Bruehl; Victoria Sweat; Wai Tsui; Shantan Reddy; Elizabeth Javier; Carol Lee; Antonio Convit
Journal:  Ophthalmology       Date:  2009-04-19       Impact factor: 12.079

6.  Chronic insulin treatment suppresses PTP1B function, induces increased PDGF signaling, and amplifies neointima formation in the balloon-injured rat artery.

Authors:  Qinghua Pu; Yingzi Chang; Chunxiang Zhang; Yi Cai; Aviv Hassid
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-11-14       Impact factor: 4.733

7.  A closer look at the role of urotensin II in the metabolic syndrome.

Authors:  Pierre-Olivier Barrette; Adel Giaid Schwertani
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-28       Impact factor: 5.555

8.  Physical activity and carotid atherosclerosis risk reduction in population with high risk for cardiovascular diseases: a cross-sectional study.

Authors:  Lulu Chen; Yuan Bi; Jian Su; Lan Cui; Renqiang Han; Ran Tao; Jinyi Zhou; Ming Wu; Yu Qin
Journal:  BMC Public Health       Date:  2022-02-07       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.